Effects of aluminum on amyloid-beta aggregation in the context of Alzheimer's disease

Arabian Journal of Chemistry

Volumn 12, Issue 8, 2019, Pages 2897-2904

  Zhang, Qiulan ^a   Zhang, Fangyuan ^a   Ni, Yongnian ^a   Kokot, Serge ^b  

^a NANCHANG UNIVERSITY   (China)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Alzheimer's disease; Chemometrics; Spectroscopy; Amyloid peptides

Indexed keywords

ATOMIC FORCE MICROSCOPY; CIRCULAR DICHROISM SPECTROSCOPY; DICHROISM; GLYCOPROTEINS; LEAST SQUARES APPROXIMATIONS; NEURODEGENERATIVE DISEASES; PEPTIDES; QUENCHING; SPECTROSCOPY;

ALZHEIMER'S DISEASE; AMYLOID BETAS; AMYLOID PEPTIDES; BINDING CONSTANT; CHEMOMETRICS; FLUORESCENCE QUENCHING METHOD; MULTIVARIATE CURVE RESOLUTION ALTERNATING LEAST-SQUARES; RANDOM-COIL STRUCTURES;

ALUMINUM COMPOUNDS;

EID: 84934312475     PISSN: 18785352     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arabjc.2015.06.019     Document Type: Article

References (35)

1. Asandei, A., Iftemi, S., Mereuta, L., Schiopu, I., Luchian, T., Probing of various physiologically relevant metals: amyloid-β peptide interactions with a lipid membrane-immobilized protein nanopore. J. Membr. Biol. 247 (2014), 523–530.
2. Bi, S.Y., Song, D.Q., Tian, Y., Zhou, X., Liu, Z.Y., Zhang, H.Q., Molecular spectroscopic study on the interaction of tetracyclines with serum albumins. Spectrochim. Acta A 61 (2005), 629–636.
3. Bush, A.I., The metallobiology of Alzheimer's disease. Trends Neurosci. 26 (2003), 207–214.
4. Chen, T.T., Wang, X.Y., He, Y.F., Zhang, C.L., Wu, Z.Y., Liao, K., Wang, J.J., Guo, Z.J., Effects of cyclen and cyclam on zinc (II)- and copper (II)-induced amyloid β-peptide aggregation and neurotoxicity. Inorg. Chem. 48 (2009), 5801–5809.
5. Chiti, F., Dobson, C.M., Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75 (2006), 333–366.
6. Dai, X.L., Hou, W.Q., Sun, Y.X., Gao, Z.L., Zhu, S.G., Jiang, Z.F., Chitosan oligosaccharides inhibit/disaggregate fibrils and attenuate amyloid β-mediated neurotoxicity. Int. J. Mol. Sci. 16 (2015), 10526–10536.
7. 2+ interactions with Alzheimer's amyloid-beta peptide. Acc. Chem. Res. 44 (2010), 1146–1155.
8. Duce, J.A., Bush, A.L., Biological metals and Alzheimer's disease: implications for therapeutics and diagnostics. Prog. Neurobiol. 92 (2010), 1–18.
9. Edelhoch, H., Spectroscopic determination of tryptophan and tyrosine in proteins. Biochemistry 6 (1967), 1948–1954.
10. Gampp, H., Maeder, M., Meyer, C.J., Zuberbuhler, A.D., Calculation of equilibrium constants from multiwavelength spectroscopic data-IV: model-free leaser-squares refinement by use of evolving factor analysis. Talanta 33 (1986), 943–951.
11. Ha, C., Ryu, J., Park, C.B., Metal ions differentially influence the aggregation and deposition of Alzheimer's β-amyloid on a solid template. Biochemistry 46 (2007), 6118–6125.
12. Kandagal, P.B., Ashoka, S., Seetharamappa, J., Vani, V., Shaikh, S.M.T., Study of the interaction between doxepin and human serum albumin by spectroscopic methods. J. Photochem. Photobiol. A 179 (2006), 161–166.
13. Khurana, R., Coleman, C., Ionescu-Zanetti, C., Carter, S.A., Krishna, V., Grover, R.K., Roy, R., Singh, S., Mechanism of thioflavin T binding to amyloid fibrils. J. Struct. Biol. 151 (2005), 229–238.
14. Klatzo, I., Wisniewski, H., Streicher, E., Experimental production of neurofibrillary degeneration: 1. Light microscopic observations. J. Neuropathol. Exp. Neurol. 24 (1965), 187–199.
15. Kumar, V., Gill, K.D., Aluminum neurotoxicity: neurobehavioural and oxidative aspects. Arch. Toxicol. 83 (2009), 965–978.
16. Lesne, S., Koh, M.T., Kotilinek, L., Kayed, R., Glabe, C.G., Yang, A., Gallagher, M., Ashe, K.H., A specific amyloid-β protein assembly in the brain impairs memory. Nature 440 (2005), 352–357.
17. Lovell, M.A., Robertson, J.D., Teesdale, W.J., Campbell, J.L., Markesbery, W.R., Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158 (1998), 47–52.
18. Mattson, M.P., Pathways towards and away from Alzheimer's disease. Nature 430 (2004), 631–639.
19. Migliore, L., Coppede, F., Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases. Mutat. Res. 667 (2009), 82–97.
20. Miller, L.M., Wang, Q., Telivala, T.P., Smith, R.J., Lanzirotti, A., Miklossy, J., Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with β-amyloid deposits in Alzheimer's disease. J. Struct. Biol. 155 (2006), 30–37.
21. Molina, H.F., Hider, R.C., Gaeta, A., Williams, R., Francis, P., Metals ions and neurodegeneration. Biometals 20 (2007), 639–654.
22. Munoz, D.G., Is exposure of aluminum a risk factor for the development of Alzheimer's disease?. Arch. Neurol. 55 (1998), 737–739.
23. Petrlova, J., Kalai, T., Maezawa, I., Altman, R., Harishchandra, G., Hong, H.S., Bricarello, D.A., Parikh, A.N., Lorigan, G.A., Jin, L.W., The influence of spin-labeled fluorene compounds on the assembly and toxicity of the A beta peptide. PLoS One, 7, 2012, e35443.
24. Rauk, A., The chemistry of Alzheimer's disease. Chem. Soc. Rev. 38 (2009), 2698–2715.
25. Ricchelli, F., Buggio, R., Drago, D., Salmona, M., Forloni, G., Negro, A., Tognon, G., Zatta, P., Aggregation/fibrillogenesis of recombinant human prion protein and Gerstmann–Sträussler–Scheinker disease peptides in the presence of metal ions. Biochemistry 45 (2006), 6724–6732.
26. Rozga, M., Kloniecki, M., Dadle, M., Bal, W., A direct determination of the dissociation constant for the Cu(II) complex of amyloid β 1–40 peptide. Chem. Res. Toxicol. 23 (2010), 336–340.
27. Storr, T., Merkel, M., Song-Zhao, G.X., Scott, L.E., Green, D.E., Bowen, M.L., Thompson, K.H., Patrick, B.O., Schugar, H.J., Orvig, C., Synthesis, characterization, and metal coordinating ability of multifunctional carbohydrate-containing compounds for Alzheimer's therapy. J. Am. Chem. Soc. 129 (2007), 7453–7463.
28. Tauler, R., Multivariate curve resolution applied to second order data. Chemom. Intell. Lab. Syst. 30 (1995), 133–146.
29. Terry, R.D., Pena, C., Experimental production of neurofibrillary degeneration: 2. Electron microscopy, phosphatase histochemistry and electron prose analysis. J. Neuropathol. Exp. Neurol. 24 (1965), 200–210.
30. Tickler, A.K., Smith, D.G., Ciccotosto, G.D., Tew, D.J., Curtain, C.C., Carrington, D., Masters, C.L., Bush, A.I., Cherny, R.A., Cappai, R., Wade, J.D., Barnham, K.J., Methylation of the imidazole side chains of the Alzheimer disease amyloid-beta peptide results in abolition of superoxide dismutase-like structures and inhibition of neurotoxicity. J. Biol. Chem. 280 (2005), 13355–13363.
31. Walton, J.R., Aluminum in hippocampal neurons from humans with Alzheimer's disease. Neurotoxicology 27 (2006), 385–394.
32. Warmlander, S., Tiiman, A., Abelein, A., Luo, J., Jarvet, J., Soderberg, K.L., Danielsson, J., Garslund, A., Biophysical studies of the amyloid β-peptide: interactions with metal ions and small molecules. ChemBioChem 14 (2013), 1692–1704.
33. Vives, M., Gragallo, R., Tauler, R., Multivariate extension of the continuous variation and mole-ratio methods for the study of the interaction of intercalators with polynucleotides. Anal. Chim. Acta 424 (2000), 105–114.
34. Zatta, P., Controversial aspects of aluminium(III) accumulation and subcompartmentation in Alzheimer's disease. Trace. Elem. Med. 10 (1993), 120–128.
35. Zatta, P., Lucchini, R., Van Rensburg, S.J., Taylor, A., The role of metals in neurodegenerative processes: aluminum, manganese and zinc. Brain Res. Bull. 62 (2003), 15–28.